Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19

Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19

US Patent 8333968 · Granted Dec 18, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tissue-homing peptide conjugates and methods of use thereof2024
Anti-PD-1 antibodies and uses thereof2024
Tumor homing and cell penetrating peptide-immuno-oncology agent complexes and me2024
Methods of treating severe insulin resistance by interfering with glucagon recep2023
Anti-CSF1R antibody and anti-PD-1 antibody combination therapy for selected canc2023
Tissue-homing peptide conjugates and methods of use thereof2023
Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic2022
Anti-PD-1 antibodies and uses thereof2022
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors2022
Methods of treatment using IL-23p19 monoclonal antibodies2022
Cartilage-homing peptide conjugates and methods of use thereof2021
Methods of treating severe insulin resistance by interfering with glucagon recep2021